Meitheal Pharmaceuticals, Inc.
17 Live Marks
18 on recordCorp.
First Filed:Mar 22, 2017Latest Filed:Oct 31, 2026Address:8700 West Bryn Mawr Ave, Chicago, IL 60631, US
Portfolio Overview
Top Classes
Class 5
PharmaceuticalsClass 44
Medical, beauty and agricultural servicesClass 42
Software, IT Services & Scientific ResearchTTAB Proceedings
No litigation activity
Top Firms
McDonnell Boehnen Hulbert & ...(Oct 2026)
18
Trademark Activity Timeline(2017 – 2026)
Trademark Portfolio
18 results
(current & previous marks)
Refine by Mark/Description🔽
Filed
Registered
Last Activity
Filters
Ownership
18
0
Status
11
6
0
1
0
Pending status
6
0
Mark Type
9
3
2
4
0
TTAB
0
0
18
16
7
7

Description: Class 5: House mark for a full line of biologic, biosimilar, and pharmaceutical preparations; anti-TNF alpha antibodies for medical purposes; monoclonal antibodies for medical purposes; anti-inflammatories; anti-inflammatory biologic, biosimilar, and pharmaceutical preparations, namely, anti-inflammatory preparations; biologic, biosimilar, and pharmaceutical preparations for the treatment of lung diseases and disorders; biologic, biosimilar, and pharmaceutical preparations for the treatment of inflammatory disorders; biologic, biosimilar, and pharmaceutical preparations for the treatment of pulmonary sarcoidosis; biologic, biosimilar, and pharmaceutical preparations for the treatment of sarcoidosis; biologic, biosimilar, and pharmaceutical preparations to reduce or prevent granulomas; biologic, biosimilar, and pharmaceutical preparations to reduce or prevent fibrosis; biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceutical preparations based on human monoclonal antibodies for the treatment of inflammatory diseases and disorders; pharmaceutical preparations containing self-replicating mRNA for the treatment of lung diseases and disorders, inflammatory disorders, pulmonary sarcoidosis, sarcoidosis; pharmaceutical preparations containing self-replicating mRNA to reduce or prevent granulomas; pharmaceutical preparations containing self-replicating mRNA to reduce or prevent fibrosis
Class 42: Research and development of biologics, biosimilars, pharmaceuticals, and self-replicating mRNA; providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and self-replicating mRNA
Class 44: Providing medical information; providing health information
Class 42: Research and development of biologics, biosimilars, pharmaceuticals, and self-replicating mRNA; providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and self-replicating mRNA
Class 44: Providing medical information; providing health information

Description: Class 42: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to oncology, infectious diseases, critical care, fertility, diabetes, immunology, inflammation; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation
Class 44: Providing medical information; providing health information; providing medical information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; providing health information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
Class 44: Providing medical information; providing health information; providing medical information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; providing health information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services

Description: Class 42: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to oncology, infectious diseases, critical care, fertility, diabetes, immunology, inflammation; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation
Class 44: Providing medical information; providing health information; providing medical information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; providing health information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
Class 44: Providing medical information; providing health information; providing medical information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; providing health information in the field of oncology, infectious diseases, critical care, fertility, diabetes, immunology, and inflammation; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services

Description: House mark for a full line of pharmaceutical preparations; pharmaceutical preparations for treating vitamin deficiency; vitamin analogs; pharmaceutical preparations for treating vitamin B12 deficiency; vitamin B12 analogs; pharmaceutical preparations for treating vitamin B9 deficiency; vitamin B9 analogs; pharmaceutical preparations for treating anemia; pharmaceutical preparations for treating vitamin B1 deficiency; vitamin B1 analogs; diuretics; diuretic preparations; pharmaceutical preparations, namely, diuretics; pharmaceutical preparations for enhancing fertility; pharmaceutical antipsychotic preparations; pharmaceutical preparations for the treatment of psychotic disorders; pharmaceutical preparations for increasing GLP-1 levels; GLP-1 receptor agonists for treating diabetes and obesity; methylene blue to treat methemoglobinemia for medical use; dye used in medical, pharmaceutical and veterinary substances; dietetic substances for medical or veterinary purposes, namely, dietary supplements containing methylene blue, in the form of tablets or capsules, or liquid form; antifungal preparations; pharmaceutical preparations, namely, antifungal preparations; pharmaceutical preparations for treating multiple sclerosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical products for treating autoimmune diseases and disorders; injectable pharmaceutical preparations for treating multiple sclerosis; syringes sold filled with injectable pharmaceutical preparations for treating multiple sclerosis; immunostimulant preparations; pharmaceutical preparations, namely, immunostimulants for increasing white blood cell production; pharmaceutical preparations for treating Paget's disease; pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely, osteoporosis, Paget's disease, and other bone-related diseases and disorders; pharmaceutical preparations for treating osteoporosis; pharmaceutical preparations for treating and preventing hypoglycemia; Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for glycemic control; pharmaceutical preparations for treating systemic inflammatory conditions; pharmaceutical preparations, namely, corticosteroids

Description: House mark for a full line of pharmaceutical preparations; pharmaceutical preparations for treating vitamin deficiency; vitamin analogs; pharmaceutical preparations for treating vitamin B12 deficiency; vitamin B12 analogs; pharmaceutical preparations for treating vitamin B9 deficiency; vitamin B9 analogs; pharmaceutical preparations for treating anemia; pharmaceutical preparations for treating vitamin B1 deficiency; vitamin B1 analogs; diuretics; diuretic preparations; pharmaceutical preparations, namely, diuretics; pharmaceutical preparations for enhancing fertility; pharmaceutical antipsychotic preparations; pharmaceutical preparations for the treatment of psychotic disorders; pharmaceutical preparations for increasing GLP-1 levels; GLP-1 receptor agonists for treating diabetes and obesity; methylene blue to treat methemoglobinemia for medical use; dye used in medical, pharmaceutical and veterinary substances; dietetic substances for medical or veterinary purposes, namely, dietary supplements containing methylene blue, in the form of tablets or capsules, or liquid form; antifungal preparations; pharmaceutical preparations, namely, antifungal preparations; pharmaceutical preparations for treating multiple sclerosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical products for treating autoimmune diseases and disorders; injectable pharmaceutical preparations for treating multiple sclerosis; syringes sold filled with injectable pharmaceutical preparations for treating multiple sclerosis; immunostimulant preparations; pharmaceutical preparations, namely, immunostimulants for increasing white blood cell production; pharmaceutical preparations for treating Paget's disease; pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely, osteoporosis, Paget's disease, and other bone-related diseases and disorders; pharmaceutical preparations for treating osteoporosis; pharmaceutical preparations for treating and preventing hypoglycemia; Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for glycemic control; pharmaceutical preparations for treating systemic inflammatory conditions; pharmaceutical preparations, namely, corticosteroids

Description: Class 42: Research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals; research and development of pharmaceuticals in the field of fertility; providing information in the field of scientific and medical research related to pharmaceuticals in the field of fertility
Class 44: Providing medical information; providing health information; providing medical information in the field of fertility; providing health information in the field of fertility
Class 44: Providing medical information; providing health information; providing medical information in the field of fertility; providing health information in the field of fertility

Description: Class 42: Research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals; research and development of pharmaceuticals in the field of fertility; providing information in the field of scientific and medical research related to pharmaceuticals in the field of fertility
Class 44: Providing medical information; providing health information; providing medical information in the field of fertility; providing health information in the field of fertility
Class 44: Providing medical information; providing health information; providing medical information in the field of fertility; providing health information in the field of fertility

Description: Class 42: Research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals; research and development of pharmaceuticals in the field of fertility; providing information in the field of scientific and medical research related to pharmaceuticals in the field of fertility
Class 44: Providing medical information; providing health information; providing medical information in the field of fertility; providing health information in the field of fertility
Class 44: Providing medical information; providing health information; providing medical information in the field of fertility; providing health information in the field of fertility

Description: Class 5: House mark for a full line of biologic, biosimilar, and pharmaceutical preparations; anti-TNF alpha antibodies for medical purposes; monoclonal antibodies for medical purposes; anti-inflammatories; anti-inflammatory biologic, biosimilar, and pharmaceutical preparations, namely, anti-inflammatory preparations; biologic, biosimilar, and pharmaceutical preparations for the treatment of lung diseases and disorders; biologic, biosimilar, and pharmaceutical preparations for the treatment of inflammatory disorders; biologic, biosimilar, and pharmaceutical preparations for the treatment of pulmonary sarcoidosis; biologic, biosimilar, and pharmaceutical preparations for the treatment of sarcoidosis; biologic, biosimilar, and pharmaceutical preparations to reduce or prevent granulomas; biologic, biosimilar, and pharmaceutical preparations to reduce or prevent fibrosis; biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceutical preparations based on human monoclonal antibodies for the treatment of inflammatory diseases and disorders; pharmaceutical preparations containing self-replicating mRNA for the treatment of lung diseases and disorders, inflammatory disorders, pulmonary sarcoidosis, sarcoidosis; pharmaceutical preparations containing self-replicating mRNA to reduce or prevent granulomas; pharmaceutical preparations containing self-replicating mRNA to reduce or prevent fibrosis
Class 42: Research and development of biologics, biosimilars, pharmaceuticals, and self-replicating mRNA; providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and self-replicating mRNA
Class 44: Providing medical information; providing health information
Class 42: Research and development of biologics, biosimilars, pharmaceuticals, and self-replicating mRNA; providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and self-replicating mRNA
Class 44: Providing medical information; providing health information

Description: Pharmaceutical preparations for reversal of effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery; pharmaceutical preparations, namely, demethylation agents; pharmaceutical preparations, namely, cholinesterase inhibitors for reversal of effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery

Description: Pharmaceutical preparations for reversal of effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery; pharmaceutical preparations, namely, demethylation agents; pharmaceutical preparations, namely, cholinesterase inhibitors for reversal of effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery

Description: Antibacterial pharmaceutical preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of diseases of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases of the digestive system; pharmaceutical preparations for the treatment of diseases of the genitourinary system; muscle relaxants; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; vitamin D analogs; pharmaceutical preparations for the treatment of endocrine diseases; anticoagulants; pharmaceutical preparations for the treatment of diseases of the circulatory system; antiemetics; pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for hormone therapy; anticholinergics; pharmaceutical preparations for use in connection with anesthesia; pharmaceutical preparations for the treatment of gastrointestinal ailments; pharmaceutical preparations for the treatment of heart rhythm disorders; vasodilators; inotropes; immunosuppressants; pharmaceutical preparations for use in connection with organ transplants; vasoconstrictors; decongestants; beta-lactamase inhibitors

Description: Antibacterial pharmaceutical preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of diseases of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases of the digestive system; pharmaceutical preparations for the treatment of diseases of the genitourinary system; muscle relaxants; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; vitamin D analogs; pharmaceutical preparations for the treatment of endocrine diseases; anticoagulants; pharmaceutical preparations for the treatment of diseases of the circulatory system; antiemetics; pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for hormone therapy; anticholinergics; pharmaceutical preparations for use in connection with anesthesia; pharmaceutical preparations for the treatment of gastrointestinal ailments; pharmaceutical preparations for the treatment of heart rhythm disorders; vasodilators; inotropes; immunosuppressants; pharmaceutical preparations for use in connection with organ transplants; vasoconstrictors; decongestants; beta-lactamase inhibitors




